Ausgabe 8/2006
Inhalt (8 Artikel)
Chronopharmacokinetics of Ciclosporin and Tacrolimus
Massimo Baraldo, Mario Furlanut
Lack of Pharmacokinetic Interaction for ISIS 113715, a 2′-0-Methoxyethyl Modified Antisense Oligonucleotide Targeting Protein Tyrosine Phosphatase 1B Messenger RNA, with Oral Antidiabetic Compounds Metformin, Glipizide or Rosiglitazone
Richard S. Geary, Joann D. Bradley, Tanya Watanabe, Younggil Kwon, Mark Wedel, Jan J. van Lier, Andrè A. van Vliet
Population Pharmacokinetics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran, in Atrial Fibrillation Patients Receiving Long-Term Anticoagulation Therapy
Sofie Bååthe, Bengt Hamrén, Mats O. Karlsson, Maria Wollbratt, Margaretha Grind, Ulf G. Eriksson
Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects
Reza Khosravan, Brian A. Grabowski, Jing-Tao Wu, Nancy Joseph-Ridge, Laurent Vernillet
Comparison of Equivalent Doses of Fentanyl Buccal Tablets and Arteriovenous Differences in Fentanyl Pharmacokinetics
Mona Danvish, Mary Kirby, Philmore Robertson Jr, Edward Hellriegel, John G. Jiang
Parametric and Nonparametric Population Methods
Johannes H. Proost, Douglas J. Eleveld